Palladyne AI Corp. (Nasdaq: $PDYN) Stock Hub: Q2 Revenue Reaches $5.8 Million, Backlog Hits $24.6 Million and Guidance Holds
Palladyne AI’s final second-quarter 2026 release confirms rapid top-line growth and another step-up in contracted work: revenue reached $5.783 million, backlog rose to $24.6 million and full-year revenue guidance remained $24 million to $27 million. The quarter also shows why the investment debate remains demanding. Gross margin was 29.1%, the operating loss widened to $13.4 million, operating cash burn increased, and the reaffirmed forecast still requires a much larger second half.
Get every Merlintrader report in real time on Telegram: join @merlintraderpub_com.
Q2 2026 results: the headline growth is real, but the second-half test remains
Palladyne AI released final results for the quarter ended June 30, 2026 before the market opened on August 6. Revenue of $5.783 million was close to the July preliminary figure and increased 470% year over year and 63% sequentially. Backlog finished at $24.6 million, 43% above March 31, after approximately $13.0 million of new contract awards during the quarter.
| Q2 2026 metric | Reported | Q2 2025 | Read-through |
|---|---|---|---|
| Revenue | $5.783M | $1.015M | Large acquired-and-organic expansion from a small base |
| Gross profit / gross margin | $1.681M / 29.1% | $0.541M / 53.3% | Gross profit dollars rose, but the hardware and services mix compressed margin |
| Operating loss | ($13.413M) | ($8.094M) | Loss widened 66% as investment and stock compensation increased |
| GAAP net loss / diluted EPS | ($12.326M) / ($0.27) | ($7.487M) / ($0.20) | Includes a $0.814M non-cash gain from warrant revaluation |
| Non-GAAP net loss / EPS | ($10.797M) / ($0.23) | ($6.448M) / ($0.17) | Excludes stock compensation, warrant revaluation and contingent consideration |
| Stock-based compensation | $2.319M | $1.141M | More than doubled year over year |
| Shares outstanding | 49.143M at June 30 | 37.746M weighted average in Q2 2025 | Equity financing remains a material part of the capital story |
Official source: Palladyne AI Reports Second Quarter 2026 Results, including the unaudited financial statements and non-GAAP reconciliation.
Executive summary
The Q2 release strengthens the evidence that Palladyne AI has become a real revenue-producing defense and aerospace platform after the November 2025 acquisitions of GuideTech, Warnke Precision Machining and MKR Fabrication. Revenue reached $5.783 million, up from $3.538 million in Q1, while backlog increased from $17.3 million to $24.6 million even after the company recognized its largest quarterly revenue total in the current configuration.
The quarter does not yet prove that the autonomy-software thesis is independently monetizing. The Q1 Form 10-Q said the company had no software product revenue at that date; the Q2 release did not provide a revenue split by acquired manufacturing, engineering services, development contracts and software products. Management described growth as driven by both acquisitions and organic expansion, but the exact mix awaits the Form 10-Q and call commentary.
The central debate has therefore moved from whether the preliminary revenue figure was real to whether the company can convert backlog fast enough while reducing cash usage. First-half revenue was $9.321 million against reiterated full-year guidance of $24 million to $27 million. That leaves $14.679 million to $17.679 million for the second half. At the $25.5 million midpoint, H2 revenue must reach $16.179 million, 74% above H1, and Q3 plus Q4 must average about $8.09 million each.
Liquidity remains adequate for the near term but is not self-funded. Cash and marketable securities ended the quarter at $43.746 million. The first-half cash-flow statement shows $20.401 million used in operations, $0.889 million of capital expenditures and $17.842 million of proceeds from common-stock issuance before offering costs. The reported share count rose 6.6% from year-end to 49.143 million. Growth, burn and dilution must be evaluated together.
Market snapshot as of the last close
| Metric | Value | Note |
|---|---|---|
| Share price, last close | $5.96 | August 5, 2026 closing price |
| Market capitalization | About $293 million | Merlintrader arithmetic using the official June 30 share count; data feeds using older counts can differ |
| Shares outstanding | 49,143,403 | Company balance sheet at June 30, 2026 |
| Current assets / liabilities | $52.036M / $8.260M | Current ratio about 6.3x |
| Cash and marketable securities | $43.746M | Roughly flat with $43.678M at March 31 |
| Short interest | About 28% of float | High short exposure can amplify moves in either direction; figure is not real-time |
| Five-year context | Severe value destruction | Spans the Sarcos era, the 2023 one-for-six reverse split and the current defense-autonomy pivot |
Market-derived figures are time-sensitive. The market-cap estimate above deliberately uses the latest company-reported share count rather than a stale vendor share base.
Verified developments, most recent first
Every item below is dated from the company’s own release or from an SEC filing. Where a dollar value is stated, the source stated it. Where no value appears, the company did not disclose one.
Reported final Q2 results: revenue of $5.783 million, backlog of $24.6 million, approximately $13.0 million of new awards, operating loss of $13.413 million, cash and securities of $43.746 million, and reaffirmed 2026 revenue and operating-cash-burn guidance.
Confirmed the second quarter 2026 conference call for Thursday, August 6, 2026 at 8:00 a.m. Eastern Time, with dial-ins, conference ID 13761965 and a webcast link. Replay available through August 20, 2026.
The US Air Force exercised a contractual option on the STRATFI contract, adding $2.9 million of new funding and taking the total contract value to more than $10.6 million. The program was originally awarded in September 2023; the first phase completed in October 2024 and additional funding followed in April 2025. The new funding covers demonstration milestones in human-guided machine learning, mixed-reality teleoperation and autonomous task execution in Air Force mission scenarios. This is funded money, not a ceiling.
Preliminary second quarter figures furnished on Form 8-K: revenue of approximately $5.8 million against $1.0 million a year earlier and $3.5 million in the first quarter; backlog of approximately $24.0 million against $17.3 million at March 31; cash, cash equivalents and marketable securities of approximately $44.0 million, roughly flat sequentially; and approximately $12.5 million of gross new contracts added during the quarter. The company stated the quarter was not closed, that the figures are unaudited and that final results could differ materially.
Executed the previously announced Air Force Research Laboratory contract known as HANGTIME, valued at $4.2 million, using SwarmOS as the baseline technology to coordinate satellites, aircraft, maritime and ground systems within a single framework. The underlying award had been announced in January 2026; the July release is the execution of the contract.
GuideTech secured a $2.3 million contract with an unnamed defense prime contractor to supply the BRAIN flight computer and FLEX flight-software framework for a low-cost kinetic counter-uncrewed-aircraft interceptor. The release describes it as a direct product sale with potential for follow-on production orders, and notes the interceptor has now been flight tested.
Awarded a pair of US Army contracts under the Army’s Disruptive Applications Broad Agency Announcement to research, develop and operationally validate SwarmOS and the Gremlin-X strike uncrewed aircraft with 4th Infantry Division warfighters across exercises in Colorado and California. No contract value was disclosed. The same release confirmed the Northern Strike 26-2 demonstration.
Announced a partnership with Israel Aerospace Industries under which Palladyne AI will manufacture, integrate and market the HARPY, HAROP and Mini HARPY loitering munition systems to the US Department of War, with exclusive US production and marketing rights. The Form 8-K filed the same day describes the arrangement under Item 7.01 as entry into a memorandum of understanding. No financial terms, no order and no revenue were disclosed.
At the annual meeting, stockholders approved an amendment and restatement of the 2021 Equity Incentive Plan increasing the shares issuable under it by 4,500,000, on a base of 47.24 million shares outstanding.
Reported first quarter results: revenue up 107% to $3.5 million, backlog of approximately $17 million reflecting about $7 million of new awards, and a reaffirmation of full-year guidance of $24 million to $27 million, with management expecting sequential growth each quarter and a ramp accelerating in the second half. The release also disclosed approximately $500,000 of follow-on BRAIN X2 orders, a Portal Space Systems contract through GuideTech with no value disclosed, and a missile propulsion subsystem contract expected to contribute nearly $1 million of 2026 revenue.
Reported fourth quarter and full year 2025 results. Fourth quarter revenue rose 118% to $1.7 million; full-year revenue fell 33% to $5.2 million; the operating loss widened to $32.4 million from $26.9 million; GAAP net income was a positive $10.0 million because of warrant fair-value movements, against a non-GAAP net loss of $25.2 million. Backlog at December 31, 2025 was $13.5 million, and the company said it had grown more than 30% to nearly $18 million by mid-February. Guidance was reiterated, and the company said it had signed its first customer for Palladyne IQ 2.0, without naming it.
Issued full-year 2026 revenue guidance of $24.0 million to $27.0 million, up from the approximately $24 million indicated in mid-November 2025, against preliminary 2025 revenue of $5.0 million to $5.5 million. Backlog at December 31, 2025 was stated as more than $13.0 million, up from about $10.0 million in mid-November, and cash as approximately $47.0 million. The release named the programs the company expects to advance during the year, including Gremlin-X, SwarmStrike and ALRRM.
Acquired 100% of the equity of GuideTech LLC, Warnke Precision Machining LLC and MKR Fabrication LLC. Aggregate consideration recorded under US GAAP was $22.6 million: $5.4 million cash, $15.9 million in 2,672,013 shares and contingent consideration valued at $1.4 million, with up to $25 million of further earnout payments in cash or stock if revenue targets are met over five years.
The numbers in pictures
Five charts built from figures in SEC filings or company releases. Bar widths are scaled to the largest value in each chart.
What Palladyne AI actually sells
The company describes itself as a US-based defense and industrial technology company delivering embodied artificial-intelligence collaborative autonomy, advanced avionics, precision-manufactured components, uncrewed aircraft and aerospace engineering services. It genuinely does all of those things, but they contribute to revenue in very different proportions.
Palladyne IQ: the industrial robotics software
Palladyne IQ is the flagship embodied artificial-intelligence platform for robotic systems working in unstructured environments. The technical claim is specific: robots learn from as few as one to five human demonstrations, generalize that learning across variations in environment and task, and execute autonomously without cloud connectivity. The platform is hardware-agnostic and supports real-time sensor fusion at the edge. The absence of a cloud dependency is what matters for defense customers, because communications in contested environments are frequently degraded or denied.
Version 2.0 became commercially available in January 2026; on March 5, 2026 the company said it had signed a first customer, and on May 5 it said initial robot systems integration with that customer was underway. The customer has never been named. The most important disclosure about Palladyne IQ, though, is in the Form 10-Q rather than in any release: the company has recognized no software product revenue to date.
The one place Palladyne IQ does generate money is the Air Force STRATFI contract, a development contract rather than a product sale, awarded in September 2023 and topped up in October 2024, April 2025 and again on July 22, 2026, bringing the cumulative award above $10.6 million. It is the company’s largest disclosed contract by value.
Palladyne Pilot and SwarmOS: the autonomy software for aircraft
Palladyne Pilot is the embodied-artificial-intelligence software for uncrewed aircraft; SwarmOS is its defense variant, rebranded at the time of the November 2025 acquisitions. The functional claim is that a single operator can command a team of autonomous systems built by different manufacturers, in a decentralized architecture that does not depend on centralized infrastructure an adversary can target. The company frames this as its differentiator against single-platform autonomy and has been building a patent position around it.
SwarmOS sits underneath most of the defense news flow of the past year: the Ivy Mass exercise with the 4th Infantry Division in June 2026, the Army Disruptive Applications contracts of June 17, the $4.2 million AFRL HANGTIME contract executed on July 7 that extends coordination to satellites for the first time, and the planned Northern Strike 26-2 demonstration. Integration work has been announced with Red Cat and with Draganfly platforms. IntelliSwarm is SwarmOS running on GuideTech’s own BRAIN X2 flight computer, integrated in roughly three weeks after the acquisitions closed and first flown in February 2026. It is the clearest evidence that the acquisitions were not purely financial: a software company that has to persuade a hardware manufacturer to host its stack has a sales problem, and a company that owns the flight computer does not.
GuideTech: avionics products and engineering services
GuideTech designs flight software, avionics and control systems for uncrewed aerial, space and missile platforms. Its products include the BRAIN family of guidance and navigation computers, the FLEX modular flight-software framework and the Reveal analytics platform, and it also sells aerospace engineering services, a line worth about $1.8 million in the first quarter of 2026, roughly half of total revenue. GuideTech is the source of the $2.3 million counter-uncrewed-aircraft contract of June 29, 2026, the approximately $500,000 of follow-on BRAIN X2 orders disclosed in the first quarter, and the Portal Space Systems contract of January 2026 for which no value was disclosed.
Palladyne Manufacturing: Warnke and MKR
Warnke Precision Machining and MKR Fabricators are precision machining and heavy fabrication businesses serving defense and industrial customers, and in the first quarter of 2026 they accounted for all of the company’s approximately $1.7 million of product revenue. They are the least glamorous part of the company, currently the most reliable, and the reason consolidated gross margin has fallen sharply: machining does not carry software economics.
Gremlin-X, SwarmStrike and ALRRM: the systems under development
Gremlin-X, formerly Project Banshee, is a reusable Group 2 strike uncrewed aircraft that delivers a munition and returns for reuse, so recurring cost per strike is driven by the munition rather than the airframe. SwarmStrike is a cruise-class autonomous munition concept and ALRRM a missile program, both named in company releases. None has a disclosed funded contract value, and the June 17, 2026 Army contracts covering Gremlin-X validation carried no stated dollar figure.
The Israel Aerospace Industries loitering munitions
The June 8, 2026 announcement gives Palladyne AI exclusive US production and marketing rights for Israel Aerospace Industries’ HARPY, HAROP and Mini HARPY loitering munitions, with Palladyne adapting them to US requirements and manufacturing components domestically while Israel Aerospace Industries supplies engineering support and key subsystems. These are systems designed to suppress and destroy enemy air defenses, a mission set where the company argues there is no direct domestic equivalent. The strategic logic is easy to follow; the accounting reality is that the Form 8-K describes this as a memorandum of understanding, no financial terms were disclosed, no US order exists in the public record, and nothing from it appears in backlog.
From Sarcos to Palladyne: why the history matters
Palladyne AI reached the public market through a special-purpose acquisition company: Rotor Acquisition Corp. completed its business combination with Sarcos Corp. on September 24, 2021, and the combined entity became Sarcos Technology and Robotics Corporation. In March 2024 the name changed to Palladyne AI Corp. Legacy hardware development had been suspended in 2023 and the Pittsburgh operation closed in early 2024.
Two legacies of that history still sit in the numbers. The first is the accumulated deficit of approximately $493.4 million at March 31, 2026, nearly twice the current market capitalization. The second is the one-for-six reverse stock split effective July 5, 2023, which is why the listed warrants under the ticker PDYNW carry a $69.00 per-share exercise price and why the five-year performance line reads the way it does. The deSPAC warrants are exercisable at $11.50 per warrant for one-sixth of a share and expire at 5:00 p.m. New York time on September 24, 2026, and the company can redeem them at $0.01 if the shares trade at or above $108.00 on a twenty-in-thirty-day test.
A reporting quirk follows from the same history. Warrants are carried as liabilities at fair value, so share-price movements flow through the income statement. In the first quarter of 2025 a $29.2 million warrant gain turned a $6.9 million operating loss into $22.8 million of reported net income; for the full year 2025 the same mechanism produced $10.0 million of GAAP net income against a $32.4 million operating loss and a $25.2 million non-GAAP net loss; in the first quarter of 2026 it reversed, with a $1.0 million loss. Reported net income here is not a measure of operating performance in either direction. The merger also left up to 4,687,500 contingent earn-out shares, of which 2,343,750 expired unissued on September 24, 2025 when the $90.00 threshold was never met; the remaining 2,343,750 require $120.00 and their window closes on the fifth anniversary of the merger.
Q2 financial position and the questions that remain after the release
The table below uses the company’s August 6 earnings release and its unaudited financial statements. Gross profit and margin are calculated from reported revenue and cost of revenue; other figures are company-reported.
| Line item (US dollars, thousands) | Q2 2026 | Q2 2025 | Comment |
|---|---|---|---|
| Revenue, net | 5,783 | 1,015 | Up 470% year over year and 63% sequentially |
| Cost of revenue | 4,102 | 474 | Shift toward products, machining and engineering services |
| Gross profit / margin | 1,681 / 29.1% | 541 / 53.3% | Gross profit dollars rose 211%; margin compressed 24.2 percentage points |
| Research and development | 4,326 | 3,125 | Up 38% |
| General and administrative | 8,143 | 4,179 | Up 95%; largest operating expense |
| Sales and marketing | 2,269 | 1,331 | Up 70% |
| Intangible amortization | 356 | – | Acquisition-related |
| Loss from operations | (13,413) | (8,094) | Widened 66% |
| Warrant liability gain | 814 | 102 | Non-cash and share-price driven |
| GAAP net loss / diluted EPS | (12,326) / (0.27) | (7,487) / (0.20) | GAAP loss benefited from warrant gain |
| Non-GAAP net loss / EPS | (10,797) / (0.23) | (6,448) / (0.17) | Company reconciliation |
| H1 cash used in operations | (20,401) | Plus $889 of H1 capex | |
| Cash / marketable securities | 33,774 / 9,972 | $43.746 million combined | |
| Receivables + unbilled receivables | 5,643 | Up from $3.510 million at year-end | |
| Accumulated deficit | (505,726) | At June 30 | |
What the conference call and Form 10-Q still need to clarify
Capital structure, the at-the-market program and the dilution record
Palladyne AI’s balance sheet still carries no conventional funded debt, but equity issuance remains the principal financing mechanism. Shares outstanding increased from 46,117,164 at December 31, 2025 to 49,143,403 at June 30, 2026, a 6.6% increase in six months. The first-half cash-flow statement separately reports $17.842 million of proceeds from common-stock issuance and $0.535 million of offering costs.
The Jefferies at-the-market program
On November 13, 2024 the company entered an open-market sale agreement with Jefferies LLC. Earlier $18 million and $30 million prospectus tranches were fully used. A further $50 million supplement was filed on August 6, 2025. At March 31, 2026 the company had used approximately $14.2 million of that third tranche, leaving roughly $35.8 million of capacity at that date.
The Q2 release makes clear that equity financing continued during the first half, but it does not provide the complete quarter-specific ATM reconciliation. The cash-flow table shows $17.842 million of common-stock issuance proceeds for H1, while cash and securities ended almost flat at $43.746 million because operations and capital expenditures used about $21.29 million. Remaining ATM capacity should therefore be updated from the Form 10-Q rather than estimated from the release alone.
The 2024 financing and outstanding warrants
On November 1, 2024 the company closed a registered direct offering of 2,790,700 shares at $2.15 per share with concurrent private-placement warrants over the same number of shares at a $2.30 exercise price. In a separate placement, the chief executive and certain directors bought 430,105 shares at $2.20 with matching warrants. The investor warrants were exercised in May 2025; the insider warrants and deSPAC warrant liabilities still affect the capital structure and can create non-cash swings in reported earnings.
Funded contracts, ceilings, memoranda and demonstrations
Defense-adjacent small caps generate a great deal of news and the items are not equivalent. A funded contract with a stated value produces revenue; a contract with no disclosed value may still be small; an option exercise adds money to an existing program; a memorandum of understanding creates a framework and nothing else; an invitation to demonstrate creates visibility. The table separates the categories on the public record as of August 6, 2026.
| Item | Date announced | Category | Disclosed value | What it is |
|---|---|---|---|---|
| US Air Force STRATFI, Palladyne IQ | Option exercised July 22, 2026 | Funded, cumulative | More than $10.6 million total, including $2.9 million added in July | Development contract awarded September 2023, first phase completed October 2024, additional funding April 2025 |
| AFRL HANGTIME, SwarmOS | Executed July 7, 2026 | Funded | $4.2 million | Multi-domain autonomy including first planned satellite integration; award had been announced in January 2026 |
| GuideTech BRAIN and FLEX for counter-UAS interceptor | June 29, 2026 | Funded product sale | $2.3 million | Unnamed defense prime, low-cost kinetic interceptor, potential follow-on production orders |
| Missile propulsion subsystem | Disclosed in Q1 2026 results | Funded | Expected to contribute nearly $1 million of 2026 revenue | Major US defense prime, existing US missile system program |
| BRAIN X2 follow-on orders | Disclosed in Q1 2026 results | Funded | Approximately $500,000 | Existing defense prime customer, commercialized X2 variant |
| US Army Disruptive Applications contracts, SwarmOS and Gremlin-X | June 17, 2026 | Funded, value not disclosed | Not disclosed | Research, development and operational validation with 4th Infantry Division across exercises in Colorado and California |
| Portal Space Systems, via GuideTech | January 2026, restated in Q1 results | Contract, value not disclosed | Not disclosed | Navigation, guidance, spacecraft modeling, embedded software and avionics for maneuverable spacecraft |
| Israel Aerospace Industries loitering munitions | June 8, 2026 | Memorandum of understanding | None disclosed | Exclusive US production and marketing rights for HARPY, HAROP and Mini HARPY; no order, no revenue, not in backlog |
| Northern Strike 26-2 | Confirmed June 17, 2026 | Demonstration | None | Joint exercise with more than 9,000 participants; SwarmOS, IntelliSwarm and Gremlin-X to be shown |
| Ivy Mass exercise | June 16, 2026 | Exercise deployment | None | SwarmOS integrated with the Army Next-Generation Command and Control prototype ecosystem |
| Acquisition earnout | November 14, 2025 | Contingent consideration | Up to $25 million ceiling | Payable in cash or stock over five years if revenue targets are met; carried at $1.5 million on the balance sheet at March 31, 2026 |
Summing only the funded items with a disclosed value gives roughly $18.6 million of cumulative contract value across the STRATFI program, HANGTIME, the counter-uncrewed-aircraft contract, the propulsion subsystem and the BRAIN X2 follow-ons. That total is spread across several years and is not the same thing as backlog, which was approximately $24.0 million at June 30, 2026 and includes the acquired businesses’ commercial work. The two should not be added together.
Management, board and governance
Ben Wolff is President and Chief Executive Officer and is the reason many holders own the stock at all. He co-founded Clearwire and later ran Sprint’s Nextel-era wireless broadband strategy, and his public communication style is unusually direct for a company this size. He has also been the architect of the pivot away from legacy hardware and of the November 2025 acquisitions, so the strategy and the executive are difficult to separate.
Dr. Denis Garagic is Chief Technology Officer and is named as principal investigator on the Army Disruptive Applications work and quoted as the technical voice on HANGTIME. Doug Dynes is President of Palladyne Aerospace and Defense, the division positioned as a mid-tier US technology prime. Matt Muta became President, Commercial and Industrial on March 2, 2026, moving off the board to take an operating role, with a mandate to build the commercial engine for Palladyne IQ after careers at Microsoft, Delta Air Lines and UnitedHealth Group.
The board and advisory structure has been deliberately weighted toward retired senior officers. Admiral Eric T. Olson, retired, sits on the board and was quoted in the Israel Aerospace Industries announcement, and the defense advisory board added Lieutenant General Sean A. Gainey, retired, in June 2026, who commanded US Army Space and Missile Defense Command and was central to joint counter-drone doctrine. Advisory boards of this kind are a normal way for a small company to acquire program knowledge and credibility with government buyers, and they are not by themselves revenue: they are an input into the probability that the company can navigate the acquisition process, not evidence that it already has.
The company remains an emerging growth company under the JOBS Act and reports as a single segment, with the chief executive as chief operating decision maker allocating resources on consolidated results. That is permitted and it is also a real limit on outside analysis: there is no public way to see whether the acquired businesses are carrying the software losses or the other way round.
Ownership, short interest and retail sentiment
On the Finviz screener, insiders hold about 30.3% and institutions about 23.4%, against a float of 32.92 million shares out of 47.24 million outstanding, and short interest is about 28.0% of that float, roughly 9.2 million shares. A short position of that size on a float that small is a structural feature of the trading: a positive surprise on August 6 can move the stock a long way on mechanics alone, and a disappointment meets very little natural buying.
Retail engagement is heavy relative to the company’s size. On Stocktwits the symbol had 8,403 watchers on the morning of August 4, 2026, with a sentiment score of 43 out of 100 on that platform’s scale. Recent posts focus on second-quarter cash burn, the read-across from the wider drone and defense complex, and price levels around $5.50 to $6.00. Those are non-professional opinions posted by individual users, not research, and are recorded only as a description of where retail attention sits.
The consensus target price shown on Finviz is $11.25 against a $5.62 close. That figure is a data-provider aggregation of published sell-side targets, reproduced as market information; it is not a Merlintrader estimate and no view is expressed on whether it is achievable. One structural point follows from the ownership mix: with insiders at roughly 30%, the supply available to trade is well under half the shares outstanding, and the at-the-market program adds to it continuously rather than in discrete events. Continuous issuance into a small float caps rallies gradually instead of causing one sharp repricing, and it makes it harder to identify a moment when the dilution is finished.
Catalyst table
| Date or window | Event | Why it matters | Status |
|---|---|---|---|
| August 6, 2026, 8:00 a.m. ET | Q2 conference call and webcast | Needed for the Q3/Q4 cadence, backlog quality, product mix and ATM details not provided in the release | Confirmed; transcript not yet available at this update |
| August 2026 | Northern Strike 26-2: SwarmOS, IntelliSwarm and Gremlin-X | Operational validation and integration proof; not itself a production order | Management said the exercise was underway on August 6 |
| September 24, 2026 | deSPAC warrants expire at 5:00 p.m. New York time | Removes a warrant liability that can swing GAAP results | Stated in the Q1 Form 10-Q |
| Q3 2026 report | Sequential revenue and cash-burn test | Management expects Q3 revenue growth and lower cash usage; both are required for the annual ranges | Date not yet announced |
| Through March 2027 | Five additional Department of War exercises | Potential path from demonstrations to funded follow-on work | Company statement in the Q2 release |
| Undated | IAI Americanization plan, procurement step or first US order | Would move HARPY, HAROP and Mini HARPY into contracted economics | No order value or date disclosed |
| Undated | Named Palladyne IQ customer or recognized software product revenue | Would prove the software layer is becoming a separate commercial line | Not disclosed in the Q2 release |
| Continuous | Sales under the Jefferies ATM | Preserves liquidity but increases the denominator for per-share value creation | Updated quarterly in SEC filings |
The constructive case and the skeptical case, side by side
- Q2 revenue of $5.783 million increased 470% year over year and 63% sequentially, and management said both acquisitions and organic growth contributed.
- Backlog increased 43% during the quarter to $24.6 million after approximately $13.0 million of new awards, even after recognizing record quarterly revenue.
- Full-year revenue guidance of $24 million to $27 million and operating cash-burn guidance of $32 million to $36 million were both reaffirmed.
- The Air Force STRATFI program now exceeds $10.6 million, HANGTIME adds a $4.2 million funded program, and BRAIN orders provide hardware revenue while autonomy programs mature.
- Cash and securities of $43.746 million and current assets more than six times current liabilities provide near-term flexibility.
- Ivy Mass validated SwarmOS across drones from four manufacturers under a single operator, and the company says five more Department of War exercises are scheduled through March 2027.
- The Q2 release did not disclose a revenue mix or confirm recognized software product revenue. Most visible current revenue still comes from acquired manufacturing, avionics and engineering operations.
- Gross margin was 29.1%, down from 53.3% a year earlier, while the operating loss widened 66% to $13.413 million.
- The forecast remains heavily back-loaded: H2 must produce $14.679 million to $17.679 million, while a majority of backlog is expected over 12-18 months.
- Management said Q2 operating cash burn was higher than Q1. H1 burn including capex was about $21.29 million, so the annual range demands a sharp reduction in H2 usage.
- Shares outstanding rose 6.6% in H1 and common-stock issuance produced $17.842 million before offering costs.
- The IAI arrangement still has no disclosed order value, and several demonstration programs remain strategically relevant without disclosed economics.
Scenario framework after the Q2 release
These scenarios organize observable execution paths; they are not forecasts and no probability is assigned.
| Scenario | What would have to be observed | Where it would show up first |
|---|---|---|
| Execution scenario | Q3 revenue grows sequentially; H2 reaches at least $14.679 million; operating cash burn falls toward $5.4 million-$7.4 million per quarter on average; gross profit dollars scale; exercises convert into funded awards | Q3 revenue, cash flow and contract disclosures |
| Slippage scenario | Guidance holds but conversion remains weighted to Q4 or early 2027; backlog grows while receivables expand; equity issuance continues at a similar pace | Q3 guidance, receivables, backlog timing and share count |
| Deterioration scenario | Sequential growth fails, guidance is reduced, H2 burn does not decline, gross profit stalls and software or IAI initiatives remain unmonetized | Q3 report, cash balance and any outlook revision |
Bottom line
Palladyne AI’s second quarter is a stronger operating print than the loss-per-share headline suggests, but it is not yet a clean proof of self-funded scale. Revenue reached $5.783 million, gross profit rose to $1.681 million and backlog climbed to $24.6 million after approximately $13.0 million of new awards. Those are real improvements, and reaffirming both revenue and cash-burn guidance signals that management still sees enough contracted work to support the 2026 plan.
The quality test is now more demanding. Gross margin was 29.1%, the operating loss widened to $13.413 million, and management acknowledged that Q2 operating cash burn increased. First-half burn was about $21.29 million including capex, while $17.842 million of common-stock issuance helped keep cash and securities near $43.7 million. The company is scaling, but shareholders are still financing that scale.
The key forward question is whether $24.6 million of backlog can convert fast enough to deliver $14.679 million-$17.679 million of H2 revenue while cash usage falls sharply. A sequentially higher Q3, a clearer funded-backlog split, evidence of software product revenue and slower share-count growth would strengthen the equity thesis. A Q4-heavy schedule, continued dilution or another rise in burn would keep the stock dependent on narrative and capital-market access.
Related research on Merlintrader
- Space, Defense & AI Stock Hubs 2026: the new infrastructure race — the index of company hubs across this sector.
- Draganfly ($DPRO) Stock Hub — the drone manufacturer whose platforms Palladyne AI has been integrating with SwarmOS.
- AeroVironment ($AVAV) Stock Hub — the established loitering-munition and small uncrewed-aircraft incumbent in the same procurement lanes.
- Rocket Lab ($RKLB) Stock Hub — a larger comparison for how backlog quality is disclosed in this sector.
- BigBear.ai ($BBAI) Stock Hub — another small-cap defense artificial-intelligence name with a heavy dilution record.
- Redwire ($RDW) Stock Hub — reporting in the same week, with a comparable at-the-market dynamic.
- Weekly Market Pulse — the week ahead across catalysts and earnings.
Primary and reference sources
- Palladyne AI Reports Second Quarter 2026 Results (August 6, 2026): final Q2 revenue, backlog, guidance, balance sheet, income statement, cash flow and non-GAAP reconciliation.
- Q2 conference call and webcast announcement: date, time, dial-ins, webcast and replay.
- July 8 Form 8-K exhibit 99.1: preliminary Q2 figures.
- Q1 2026 Form 10-Q: funded backlog, acquisitions, ATM disclosures, warrants and software-revenue status at March 31.
- 2025 Form 10-K: history, risk factors, acquisitions and financial statements.
- IAI partnership release and Form 8-K.
- STRATFI option exercise: $2.9 million added and total program value above $10.6 million.
- AFRL HANGTIME contract and GuideTech counter-UAS contract.
- US Army Disruptive Applications contracts.
- Palladyne AI filings on SEC EDGAR and company releases.
Company financial figures are from the August 6 release and linked SEC filings. Calculated gross margin, H2 requirements, market capitalization and cash-burn arithmetic are identified as Merlintrader calculations. Market-derived figures are time-sensitive. Conference-call transcript evidence was not yet available at publication.
Join the Merlintrader community
Real-time reports on Telegram: @merlintraderpub_com. Discussion and questions on Reddit: r/MerlintraderPub.
Educational disclaimer
This article is for informational and educational purposes only and does not constitute investment advice, financial advice, legal advice, tax advice, a solicitation, or a recommendation to buy, sell or hold any security. It has been prepared in line with U.S. Securities and Exchange Commission guidance on financial publishing and does not create any adviser relationship. Small and mid-cap equities, defense technology companies, artificial-intelligence and robotics stocks, and companies with negative earnings, continuous equity issuance or complex capital structures can be highly volatile and risky. Readers should conduct their own due diligence, review official company filings and consult a qualified financial adviser where appropriate. The author and Merlintrader are not acting as registered investment advisers or broker-dealers. All scenarios are analytical frameworks, not predictions or guarantees. Market prices, filings, ownership data, analyst views and company fundamentals can change quickly, and figures quoted here are accurate as of August 6, 2026.
Additional site information is available at Merlintrader Disclaimer and Terms of use and privacy information.
Get these reports in real time
Join the Merlintrader Telegram channel and receive every new deep dive and market update the moment it goes live.
Join @merlintraderpub_com on TelegramSpace, Defense & AI Catalyst Calendar
Every dated catalyst across the sector in one free, filterable calendar.
Open the Free Catalyst Calendar


